CFTR and cystic fibrosis: CFTR modulators improve but do not normalize airway hydration, nor can they restore CF-related bronchiectasis, and as a result, CF airways can remain coated with viscous mucus layers which may persistently harbor S. aureus and/or P. aeruginosa (12, 13).